Flow cytometric analysis of apoptosis and BCL-2 in primary breast carcinomas: Clinical and biological implications

被引:0
作者
Steck, K
McDonnell, T
Sneige, N
ElNaggar, A
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC PATHOL,HOUSTON,TX 77030
来源
CYTOMETRY | 1996年 / 24卷 / 02期
关键词
flow cytometry; mammary carcinoma; bcl-2; apoptosis;
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Analysis of programmed cell death (apoptosis), of bcl-2, a critical regulator of this process, and of the proliferative fraction may provide detailed information on the biologic characteristics of tumor cell populations, To investigate the potential role of these parameters in assessing mammary carcinoma, we adapted flow cytometric procedures for concurrent measurement of apoptosis, bcl-2 expression, and cell proliferation in 54 primary breast carcinomas and correlated the findings with traditional clinicopathologic information. Overall, a significant inverse relationship between apoptosis levels and bcl-2 expression was observed (P = 0.005). Apoptosis levels correlated significantly with DNA aneuploidy (P = 0.03) and S + G2M fractions (P = 0.005) of these tumors, A significant correlation between bcl-2 expression and estrogen receptor positivity (P = 0.05) and DNA diploidy (P = 0.02) was noted. Bcl-2 expression, however, was inversely correlated with S + G2M fractions (P = 0.001), We conclude that analysis of apoptosis and bcl-2 by flow cytometry allows further characterization of tumor cell populations that may be useful for prognostic and therapeutic management of breast carcinoma. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 50 条
  • [41] Apoptosis and BCL-2 expression in prostate cancer: Significance in clinical outcome after brachytherapy
    Szostak, MJ
    Kaur, P
    Amin, P
    Jacobs, SC
    Kyprianou, N
    JOURNAL OF UROLOGY, 2001, 165 (06) : 2126 - 2130
  • [42] B cell compartments in multiple myeloma: flow cytometric analysis of their labelling indices and Bcl-2 protein expression
    Trimoreau, F
    Gachard, N
    Jaccard, A
    Toni, FB
    Bordessoule, D
    Praloran, V
    HEMATOLOGY AND CELL THERAPY, 1998, 40 (01) : 11 - 16
  • [43] Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages
    Olie, RA
    Hafner, C
    Küttel, R
    Sigrist, B
    Willers, J
    Dummer, R
    Hall, J
    Stahel, RA
    Zangemeister-Wittke, U
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (03) : 505 - 512
  • [44] Clinical significance of bcl-2 gene expression in human breast cancer tissues
    Shunzo Kobayashi
    Hirotaka Iwase
    Yukashi Ito
    Hiroko Yamashita
    Hiroji Iwata
    Toshinari Yamashita
    Kazuko Ito
    Tatsuya Toyama
    Takaaki Nakamura
    Akira Masaoka
    Breast Cancer Research and Treatment, 1997, 42 : 173 - 181
  • [45] Molecular characterization of apoptosis by the immunohistochemical evaluation of Bcl-2 in breast cancer
    Zaha, Dana Carmen
    Lazar, Elena
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2012, 53 (01) : 155 - 160
  • [46] The diagnostic value of flow cytometric analysis of DNA content heterogeneity for breast carcinomas
    He, LX
    Mao, YR
    Zhou, JL
    Yang, F
    Zhang, GM
    Feng, ZH
    PHOTONICS AND IMAGING IN BIOLOGY AND MEDICINE, 2003, 5254 : 393 - 398
  • [47] Differential expression of Bax and Bcl-2 in the assessment of cellular dynamics in fine-needle samples of primary breast carcinomas
    Maciorowski, Z
    Klijanienko, J
    Padoy, E
    Mosseri, V
    Diéras, V
    El-Naggar, AK
    Chevillard, S
    Vielh, P
    CYTOMETRY, 2000, 42 (05): : 264 - 269
  • [48] Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy
    Ellis, PA
    Smith, IE
    Detre, S
    Burton, SA
    Salter, J
    A'Hern, R
    Walsh, G
    Johnston, SRD
    Dowsett, M
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 48 (02) : 107 - 116
  • [49] EXPRESSION OF BCL-2 IN PRIMARY BREAST-CANCER AND ITS CORRELATION WITH TUMOR PHENOTYPE
    NATHAN, B
    GUSTERSON, B
    JADAYEL, D
    OHARE, M
    ANBAZHAGAN, R
    JAYATILAKE, H
    EBBS, S
    MICKLEM, K
    PRICE, K
    GELBER, R
    REED, R
    SENN, HJ
    GOLDHIRSCH, A
    DYER, MJS
    ANNALS OF ONCOLOGY, 1994, 5 (05) : 409 - 414
  • [50] Expression and clinical implications of bcl-2 in extrahepatic bile duct carcinoma: Its relationship with biological features
    Ito, Y
    Takeda, T
    Sakon, M
    Tsujimoto, M
    Matsuura, N
    ANTICANCER RESEARCH, 2000, 20 (5C) : 3891 - 3895